UPEFinder

UPEFinder infers functional annotations for uncharacterized human proteins (uPE1 proteins and uncharacterized missing proteins, uMPs) by analyzing public RNA-Seq coexpression data and network topology using a guilt-by-association approach and PageRank.


Key Features:

  • Guilt-by-Association Analysis: Leverages public RNA-Seq datasets to correlate uPE1 proteins and uMPs with PE1 proteins and construct a protein coexpression network.
  • PageRank Algorithm Application: Applies the PageRank algorithm to the constructed network to prioritize nodes indicative of potential biological annotations based on gene expression correlations.
  • Database Storage: Stores inferred annotations and network data in a dedicated database.

Scientific Applications:

  • Functional Annotation of Uncharacterized Proteins: Provides inferred biological annotations for uPE1 proteins and uMPs to support characterization efforts.
  • Hypothesis Generation for Protein Function and Disease Implications: Generates hypotheses about protein functions and their potential implications in human diseases using gene expression and network analysis.
  • Support for the Human Proteome Project (HPP): Assists HPP efforts to characterize missing and uncharacterized proteins through systematic annotation from expression-derived networks.

Methodology:

Uses public RNA-Seq datasets to compute correlations between uncharacterized proteins and PE1 proteins, constructs a protein coexpression network, applies PageRank to prioritize nodes, and stores results in a dedicated database.

Topics

Details

License:
MIT
Programming Languages:
Python
Added:
1/18/2021
Last Updated:
3/9/2021

Operations

Publications

González-Gomariz J, Serrano G, Tilve-Álvarez CM, Corrales FJ, Guruceaga E, Segura V. UPEFinder: A Bioinformatic Tool for the Study of Uncharacterized Proteins Based on Gene Expression Correlation and the PageRank Algorithm. Journal of Proteome Research. 2020;19(12):4795-4807. doi:10.1021/acs.jproteome.0c00364. PMID:33155801.

PMID: 33155801
Funding: - Ministerio de Ciencia, Innovaci?n y Universidades: RTI2018-101481-B-100 - European Regional Development Fund: RTI2018-101481-B-100) - Instituto de Salud Carlos III: PT17/0019/0013

Links